111 related articles for article (PubMed ID: 1280470)
1. Contact factor proteases and the complexes formed with alpha 2-macroglobulin can interfere in protein C assays by cleaving amidolytic substrates.
Mackie IJ; Gallimore M; Machin SJ
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):589-95. PubMed ID: 1280470
[TBL] [Abstract][Full Text] [Related]
2. Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.
Briseid K; Hoem NO; Johannesen S; Haug K
Thromb Res; 1995 May; 78(3):239-50. PubMed ID: 7631304
[TBL] [Abstract][Full Text] [Related]
3. Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.
Scott CF; Sinha D; Seaman FS; Walsh PN; Colman RW
Blood; 1984 Jan; 63(1):42-50. PubMed ID: 6606454
[TBL] [Abstract][Full Text] [Related]
4. Components of the kallikrein-kinin system and the spontaneous cold activation of factor VII in human plasma.
Laake K; Gjonnaess H; Fagerhol MK
Acta Pharmacol Toxicol (Copenh); 1973; 33(3):229-40. PubMed ID: 4800785
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
6. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.
Fossum S; Hoem NO; Johannesen S; Korpberget M; Nylund E; Sandem S; Briseid K
Thromb Res; 1994 Jun; 74(5):477-85. PubMed ID: 8085248
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
8. Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia.
Minnema MC; Pajkrt D; Wuillemin WA; Roem D; Bleeker WK; Levi M; van Deventer SJ; Hack CE; ten Cate H
Blood; 1998 Nov; 92(9):3294-301. PubMed ID: 9787166
[TBL] [Abstract][Full Text] [Related]
9. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
Orthner CL
J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
[TBL] [Abstract][Full Text] [Related]
10. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.
Harpel PC; Lewin MF; Kaplan AP
J Biol Chem; 1985 Apr; 260(7):4257-63. PubMed ID: 2579948
[TBL] [Abstract][Full Text] [Related]
11. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
Hoem NO; Johannesen S; Briseid K
Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
[TBL] [Abstract][Full Text] [Related]
12. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
Czendlik C; Lämmle B; Duckert F
Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
[TBL] [Abstract][Full Text] [Related]
13. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
Harpel PC
J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
[TBL] [Abstract][Full Text] [Related]
14. Autoactivation of human plasma prekallikrein.
Tans G; Rosing J; Berrettini M; Lämmle B; Griffin JH
J Biol Chem; 1987 Aug; 262(23):11308-14. PubMed ID: 2440889
[TBL] [Abstract][Full Text] [Related]
15. Studies on proteases and alpha-macroglobulin activity in amphibian blood plasma.
Kumar RS
Indian J Exp Biol; 1997 Nov; 35(11):1198-202. PubMed ID: 9567750
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of kallikrein-like protease activity in nonactivated plasma of patients with Cooley's anemia.
Andrew M; Manno M; Karpatkin M
Blood; 1983 Feb; 61(2):232-7. PubMed ID: 6336956
[TBL] [Abstract][Full Text] [Related]
17. [Study of chromogenic substrate on protein C activity assay--in patients treated with warfarin].
Sakata T; Hatsuyama H; Kitamura T; Uchida K; Katayama Y; Matsuyama T
Rinsho Byori; 1990 Aug; 38(8):937-41. PubMed ID: 2232257
[TBL] [Abstract][Full Text] [Related]
18. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
Scott CF; Pixley RA; Colman RW
Thromb Res; 1987 Dec; 48(6):685-700. PubMed ID: 3501619
[TBL] [Abstract][Full Text] [Related]
19. A sequential mechanism for exosite-mediated factor IX activation by factor XIa.
Geng Y; Verhamme IM; Messer A; Sun MF; Smith SB; Bajaj SP; Gailani D
J Biol Chem; 2012 Nov; 287(45):38200-9. PubMed ID: 22961984
[TBL] [Abstract][Full Text] [Related]
20. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
Ito R; Statland BE
Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
